KPC Pharmaceuticals Inc (600422) — Cash Flow Reinvestment Rate
KPC Pharmaceuticals Inc (600422) has a Cash Flow Reinvestment Rate of 7.94x as of December 2025, reinvesting CN¥898.19 Million (capex CN¥32.53 Million plus investments CN¥865.66 Million) from operating cash flow of CN¥113.07 Million. See KPC Pharmaceuticals Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
KPC Pharmaceuticals Inc Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for KPC Pharmaceuticals Inc across 25 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of KPC Pharmaceuticals Inc.
Annual Cash Flow Reinvestment Rate for KPC Pharmaceuticals Inc (1999–2025)
Year-by-year capital reinvestment analysis for KPC Pharmaceuticals Inc. See 600422 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.22x | CN¥642.88 Million | CN¥289.24 Million | CN¥90.56 Million | ▲ +633.6% |
| 2024 | 0.30x | CN¥244.84 Million | CN¥808.07 Million | CN¥79.43 Million | ▼ -49.1% |
| 2023 | 0.60x | CN¥448.86 Million | CN¥754.33 Million | CN¥109.64 Million | ▼ -55.1% |
| 2022 | 1.32x | CN¥336.35 Million | CN¥253.90 Million | CN¥101.75 Million | ▼ -25.1% |
| 2021 | 1.77x | CN¥444.88 Million | CN¥251.63 Million | CN¥236.17 Million | ▲ +219.0% |
| 2020 | 0.55x | CN¥227.19 Million | CN¥409.94 Million | CN¥158.73 Million | ▼ -56.1% |
| 2019 | 1.26x | CN¥541.78 Million | CN¥429.50 Million | CN¥347.35 Million | ▼ -32.1% |
| 2018 | 1.86x | CN¥654.55 Million | CN¥352.07 Million | CN¥217.26 Million | ▲ +40.2% |
| 2017 | 1.33x | CN¥321.69 Million | CN¥242.53 Million | CN¥268.74 Million | ▲ +75.0% |
| 2016 | 0.76x | CN¥235.78 Million | CN¥311.16 Million | CN¥203.45 Million | ▼ -77.4% |
| 2015 | 3.35x | CN¥1.60 Billion | CN¥476.62 Million | CN¥210.82 Million | ▲ +469.8% |
| 2014 | 0.59x | CN¥222.98 Million | CN¥379.13 Million | CN¥222.98 Million | ▼ -33.1% |
| 2013 | 0.88x | CN¥212.65 Million | CN¥241.97 Million | CN¥212.65 Million | ▲ +52.2% |
| 2012 | 0.58x | CN¥123.22 Million | CN¥213.33 Million | CN¥123.22 Million | ▲ +89.0% |
| 2011 | 0.31x | CN¥42.85 Million | CN¥140.24 Million | CN¥42.85 Million | ▼ -56.7% |
| 2010 | 0.71x | CN¥64.16 Million | CN¥90.82 Million | CN¥64.16 Million | ▲ +382.6% |
| 2009 | 0.15x | CN¥18.82 Million | CN¥128.57 Million | CN¥18.82 Million | ▲ +2.4% |
| 2008 | 0.14x | CN¥13.09 Million | CN¥91.59 Million | CN¥13.09 Million | ▲ +11.5% |
| 2007 | 0.13x | CN¥16.67 Million | CN¥130.06 Million | CN¥16.67 Million | ▼ -73.0% |
| 2006 | 0.47x | CN¥29.03 Million | CN¥61.25 Million | CN¥29.03 Million | ▼ -9.5% |
| 2003 | 0.52x | CN¥32.08 Million | CN¥61.23 Million | CN¥32.08 Million | ▼ -88.6% |
| 2002 | 4.58x | CN¥79.62 Million | CN¥17.38 Million | CN¥79.62 Million | ▲ +1594.6% |
| 2001 | 0.27x | CN¥18.13 Million | CN¥67.07 Million | CN¥18.13 Million | ▼ -46.7% |
| 2000 | 0.51x | CN¥24.20 Million | CN¥47.76 Million | CN¥24.20 Million | ▲ +141.1% |
| 1999 | 0.21x | CN¥12.67 Million | CN¥60.24 Million | CN¥12.67 Million | — |